A Prospective Randomized, Multi-center Study to Assess the Safety and Efficacy of Mucosta (Rebamipide), in Combination With Omeprazole as Adjuvant Therapy in Gastric Ulcer Patients.

Trial Profile

A Prospective Randomized, Multi-center Study to Assess the Safety and Efficacy of Mucosta (Rebamipide), in Combination With Omeprazole as Adjuvant Therapy in Gastric Ulcer Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2013

At a glance

  • Drugs Rebamipide (Primary) ; Omeprazole
  • Indications Duodenal ulcer; Gastric ulcer
  • Focus Therapeutic Use
  • Acronyms MGES
  • Most Recent Events

    • 01 Feb 2013 Actual initiation date Oct 2010 added as reported by ClinicalTrials.gov.
    • 01 Aug 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top